Previous Close | 3.8900 |
Open | 3.8700 |
Bid | 2.9600 x 200 |
Ask | 4.9200 x 200 |
Day's Range | 3.8301 - 4.1600 |
52 Week Range | 0.2530 - 4.3600 |
Volume | |
Avg. Volume | 1,574,753 |
Market Cap | 49.903M |
Beta (5Y Monthly) | 3.57 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.6500 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.00 |
HOUSTON, TX, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today released a letter to shareholders from its CEO Mark White: Dear Shareholders, I am pleased to provide an update on Nexalin Technologies’ recent milestones, which underscore our commitment to advancing our patented Deep Intracranial Frequency Stimulation (DIFS) technology for the treatment of neurological and mental health conditions. The past months have brought excitin
Just because a business does not make any money, does not mean that the stock will go down. For example, Nexalin...